About Us

Founded in 2014 in Singapore, Skyline Galaxy Capital has been working closely with universities and research institutions in various countries to invest in biotechnology startups with solid science, novel technologies, and sizeable unmet market needs.

We provide the companies with capital, resources and synergies, assist them to transform their technologies from scientific concepts to commercialized products that benefit the public, and help the companies to grow from the formation to the realization of their values.